Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Large Volume Increase – What’s Next?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) saw unusually-high trading volume on Friday . Approximately 413,801 shares were traded during mid-day trading, an increase of 270% from the previous session’s volume of 111,869 shares.The stock last traded at $10.7350 and had previously closed at $10.83.

Shionogi & Co., Ltd. Unsponsored ADR Stock Performance

The stock’s 50 day moving average price is $10.31 and its 200 day moving average price is $9.18. The company has a current ratio of 5.84, a quick ratio of 5.21 and a debt-to-equity ratio of 0.01. The company has a market cap of $18.29 billion, a price-to-earnings ratio of 14.14, a P/E/G ratio of 1.05 and a beta of 0.17.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.09. The business had revenue of $966.53 million during the quarter, compared to the consensus estimate of $848.42 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.82% and a return on equity of 13.70%. On average, analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current fiscal year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.